Hansa Biopharma to host Year-end report 2025 conference call
Lund, Sweden, 26 January, 2026. Hansa Biopharma, “Hansa” (Nasdaq Stockholm: HNSA), will publish its year-end report for January – December 2025 on Wednesday 11 February, 2026. Interested parties may join the Company’s quarterly conference call on the same date at 14:00 CET / 8:00 AM EST. The event will be hosted by Renée Aguiar-Lucander, CEO, Evan Ballantyne, CFO, Richard Philipson, CMO, and Maria Törnsén, COO and President U.S. During the call, management will review the Company’s year-end financial results and provide a business and pipeline update. The presentation will be held in English.
